"Last week, an independent data and safety monitoring board recommended immediately ending a trial being carried out by the Haitian Group for the Study of Kaposi's Sarcoma and Immune Deficiency Disorders (GHESKIO) Centers, because the evidence in favour of earlier treatment was so overwhelming."
Read more in IRIN (UN), June 10, 2009.
0 comments:
Post a Comment